EcoDrugPlus

Toll Like Receptor 2

Ensembl ID : ENSVPAG00000006391
Gene Symbol: TLR2
3 Cross references
251 Possible Orthologues:

Toll Like Receptor 4

Ensembl ID : ENSVPAG00000008286
Gene Symbol: TLR4
1 Cross references
127 Possible Orthologues:

Toll Like Receptor 7

Ensembl ID : ENSVPAG00000000324
Gene Symbol: TLR7
1 Cross references
197 Possible Orthologues:

Toll Like Receptor 8

Ensembl ID : ENSVPAG00000000326
Gene Symbol: TLR8
1 Cross references
200 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSVPAG00000005113
Gene Symbol: TAAR1
1 Cross references
602 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSVPAG00000010404
Gene Symbol: TGFBR1
1 Cross references
230 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSVPAG00000000380
Gene Symbol: TRPA1
1 Cross references
226 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily M Member 8

Ensembl ID : ENSVPAG00000002292
Gene Symbol: TRPM8
1 Cross references
158 Possible Orthologues:

Transthyretin

Ensembl ID : ENSVPAG00000003440
Gene Symbol: TTR
1 Cross references
164 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSVPAG00000010206
Gene Symbol: TPH1
1 Cross references
255 Possible Orthologues:

Tubulin Alpha 1a

Ensembl ID : ENSVPAG00000005749
Gene Symbol: TUBA1A
3 Cross references
140 Possible Orthologues:

Tubulin Alpha 1c

Ensembl ID : ENSVPAG00000005748
Gene Symbol: TUBA1C
1 Cross references
119 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).